A Phase 2/3 Study of Osivelotor in Sickle Cell Disease
Recruiting Phase 2,Phase 3 NCT05431088
Study Description
A Study to Evaluate the Safety and Effectiveness of a New Drug Called Osivelotor in People with Sickle Cell Disease
Study Details
- Registry ID:
- NCT05431088
- Conditions:
- Sickle Cell Disease
- Phase:
- Phase 2,Phase 3
- Target Enrollment:
- 389 participants
- Start Date:
- Age Range:
- 12–999 years
- Healthy Volunteers:
- No
Study Locations (68 sites)
-
Lagos University Teaching Hospital Haematology
Idi Araba, Lagos, Nigeria -
Lagos University Teaching Hospital
Lagos, Nigeria -
University College Hospital Ibadan
Ibadan, Oyo/ibadan North, Nigeria -
University College Hospital
Oyo, Nigeria -
Aminu Kano Teaching Hospital
Kano, Nigeria -
KEMRI/CRDR, Siaya, KEMRI Clinical Research Annex
Kisumu, Siaya County, Kenya -
KEMRI/CRDR, Siaya, KEMRI Clinical Research Annex
Kisumu, Siaya, Kenya -
Multihemo Servicos Medicos S/A
Recife, PE, Brazil -
Multihemo Servicos Medicos S/A
Recife, Pernambuco, Brazil -
Gertrude's Children's Hospital
Nairobi, Kenya -
Kenya Medical Research Institute - Centre for Respiratory Disease Research
Nairobi, Kenya -
Center for Research In Therapeutic Sciences (CREATES), Strathmore University Medical Centre
Nairobi, Kenya -
Hospital Universitario Professor Edgar Santos
Salvador, Estado de Bahia, Brazil -
Hospital Universitario Professor Edgar Santos
Salvador, Bahia, Brazil -
Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti - HEMORIO
Rio de Janeiro, Brazil -
HEMORIO - Unidade de Pesquisa Clínica
Rio De Janeiro, Brazil -
Nini Hospital s.a:l
Tripoli, Lebanon -
University Hospitals Bristol and Weston NHS Foundation Trust
Bristol, United Kingdom -
Bristol Royal Infirmary
Bristol, United Kingdom -
Esho Empresa De Servicos Hospitalares S.A/ Hospital Samaritano Higienopolis
Sao Paulo, Brazil -
Real e Benemerita Associacao Portuguesa de Sao Paulo
Sao Paulo, Brazil -
Casa de Saude Santa Marcelina
São Paulo, São Paulo, Brazil -
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo
São Paulo, Brazil -
BP A Beneficência Portuguesa de São Paulo
São Paulo, São Paulo, Brazil -
Esho Empresa de Servicos Hospitalares S A
São Paulo, SÃO Paulo- Brasil, Brazil -
Hospital Das Clinicas da Faculdade de Medicina de Ribeirão Preto - USP
Ribeirão Preto, SÃO Paulo, Brazil -
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto
São José Do Rio Preto, SÃO Paulo, Brazil -
Nirmal Hospital Pvt Ltd
Surat, Gujarat, India -
Chopda Medicare & Research Centre Pvt. Ltd: Magnum Heart Institute
Nashik, Maharashtra, India -
Smilow Cancer Center at Yale New Haven Hospital
New Haven, Connecticut, United States -
Smilow Cancer Hospital
New Haven, Connecticut, United States -
Edward Jenner Research Group LLC.
Miami, Florida, United States -
Edward Jenner Research Group, LLC
Plantation, Florida, United States -
Palm Beach Children's Hospital
West Palm Beach, Florida, United States -
St. Mary's Medical Center
West Palm Beach, Florida, United States -
Palm Beach Children's Hospital at St. Mary's Medical Center
West Palm Beach, Florida, United States -
Pediatric Hematology / Oncology a division of Kidz Medical services
West Palm Beach, Florida, United States -
Virginia Commonwealth University- Clinical Research Services Unit
Richmond, Virginia, United States -
Clinical Research Services Unit - Virginia Commonwealth University Medical Center
Richmond, Virginia, United States -
Children's National Hospital
Washington D.C., District of Columbia, United States -
Children's National Hospital
Washington, District of Columbia, United States -
Inova Center for Personalized Health
Fairfax, Virginia, United States -
Inova Schar Cancer Institute
Fairfax, Virginia, United States -
UNC IDS
Morrisville, North Carolina, United States -
UNC Eastowne Medical Office Building - Consent Only
Chapel Hill, North Carolina, United States -
Clinical & Translational Research Center (CTRC)
Chapel Hill, North Carolina, United States -
UNC Hospitals, The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States -
UNC Health
Chapel Hill, North Carolina, United States -
Sonar Clinical Research
Riverdale, Georgia, United States -
Sonar Clinical Research
Atlanta, Georgia, United States -
Alpha Clinical Research of Georgia LLC
Atlanta, Georgia, United States -
Alpha Clinical Research Georgia
Dunwoody, Georgia, United States -
University Medical Center, New Orleans
New Orleans, Louisiana, United States -
Mississippi Center for Advanced Medicine
Madison, Mississippi, United States -
Our lady of the Lake Hospital
Baton Rouge, Louisiana, United States -
LSU Health Baton Rouge-North Clinic
Baton Rouge, Louisiana, United States -
Our Lady of the Lake Regional Medical Center
Baton Rouge, Louisiana, United States -
University of Illinois at Chicago Clinical Research Center
Chicago, Illinois, United States -
Lynn Institute of the Ozarks
Little Rock, Arkansas, United States -
The University of Texas Health Science Center at Houston
Houston, Texas, United States -
Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU)
Houston, Texas, United States -
McGovern Medical School/Health Science Center Houston
Houston, Texas, United States -
McGovern Medical School at UTHealth
Houston, Texas, United States -
UT Physicians Comprehensive Sickle Cell Clinic
Houston, Texas, United States -
Truman Medical Center
Kansas City, Missouri, United States -
University Health
Kansas City, Missouri, United States -
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Torrance, California, United States -
AMR Clinical - Mobile
Mobile, Alabama, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.